Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis.
Much progress has been made over the last decade in diagnosing and treating CDC, a chronic and debilitating infection that interferes with the delivery of intensive cytotoxic chemotherapy in patients with leukemia. The use of fluconazole prophylaxis in these patients has decreased the incidence of CDC dramatically. The greatest future challenges are gaining a better understanding of its pathophysiology, and the continued development of effective diagnostic and therapeutic strategies to treat this unusual manifestation of systemic candidiasis.
Kontoyiannis
D P
DP
Department of Internal Medicine Specialties, University of Texas MD Anderson Cancer Center, Houston, USA.
Luna
M A
MA
Samuels
B I
BI
Bodey
G P
GP
D000935:Antifungal Agents / Q000627:therapeutic use*; D002175:Candida / Q000254:growth & development*; D002177:Candidiasis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D006801:Humans; D015994:Incidence; D008099:Liver / Q000000981:diagnostic imaging / Q000382:microbiology* / Q000473:pathology; D011859:Radiography; D013154:Spleen / Q000000981:diagnostic imaging / Q000382:microbiology* / Q000473:pathology; D014463:Ultrasonography
D000935:Antifungal Agents